Nurix Therapeutics (NRIX) Assets Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) Assets Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -9.47% |
| Feb 28, 2026 | 3.43% |
| Nov 30, 2025 | 2.81% |
| Aug 31, 2025 | 1.73% |
| May 31, 2025 | 15.76% |
| Feb 28, 2025 | 96.70% |
| Nov 30, 2024 | 88.23% |
| Aug 31, 2024 | 66.65% |
| May 31, 2024 | 45.75% |
| Feb 29, 2024 | -15.53% |
| Nov 30, 2023 | -14.68% |
| Aug 31, 2023 | -32.90% |
| May 31, 2023 | -11.08% |
| Feb 28, 2023 | -15.44% |
| Nov 30, 2022 | -12.59% |
| Aug 31, 2022 | -6.84% |
| May 31, 2022 | -23.88% |
| Feb 28, 2022 | 10.35% |
| Nov 30, 2021 | 20.29% |
| Aug 31, 2021 | 19.71% |